IE75728B1 - 2-substituted quinolines processes for their preparation and their use in medicaments - Google Patents

2-substituted quinolines processes for their preparation and their use in medicaments

Info

Publication number
IE75728B1
IE75728B1 IE920557A IE920557A IE75728B1 IE 75728 B1 IE75728 B1 IE 75728B1 IE 920557 A IE920557 A IE 920557A IE 920557 A IE920557 A IE 920557A IE 75728 B1 IE75728 B1 IE 75728B1
Authority
IE
Ireland
Prior art keywords
carbon atoms
chain
straight
general formula
substituted
Prior art date
Application number
IE920557A
Other languages
English (en)
Other versions
IE920557A1 (en
Inventor
Siegfried Raddatz
Klaus-Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Christian Kohlsdorfer
Reiner Muller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IE920557A1 publication Critical patent/IE920557A1/en
Publication of IE75728B1 publication Critical patent/IE75728B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Earth Drilling (AREA)
IE920557A 1991-02-22 1992-02-21 2-substituted quinolines processes for their preparation and their use in medicaments IE75728B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4105551A DE4105551A1 (de) 1991-02-22 1991-02-22 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
IE920557A1 IE920557A1 (en) 1992-08-26
IE75728B1 true IE75728B1 (en) 1997-09-24

Family

ID=6425643

Family Applications (1)

Application Number Title Priority Date Filing Date
IE920557A IE75728B1 (en) 1991-02-22 1992-02-21 2-substituted quinolines processes for their preparation and their use in medicaments

Country Status (20)

Country Link
EP (1) EP0499926B1 (enrdf_load_stackoverflow)
JP (1) JPH0592957A (enrdf_load_stackoverflow)
KR (1) KR920016424A (enrdf_load_stackoverflow)
AT (1) ATE142623T1 (enrdf_load_stackoverflow)
AU (1) AU641585B2 (enrdf_load_stackoverflow)
CZ (1) CZ282723B6 (enrdf_load_stackoverflow)
DE (2) DE4105551A1 (enrdf_load_stackoverflow)
DK (1) DK0499926T3 (enrdf_load_stackoverflow)
ES (1) ES2091958T3 (enrdf_load_stackoverflow)
FI (1) FI920732A7 (enrdf_load_stackoverflow)
GR (1) GR3021014T3 (enrdf_load_stackoverflow)
HU (1) HUT67037A (enrdf_load_stackoverflow)
IE (1) IE75728B1 (enrdf_load_stackoverflow)
IL (1) IL101009A (enrdf_load_stackoverflow)
MY (1) MY108459A (enrdf_load_stackoverflow)
NZ (1) NZ241654A (enrdf_load_stackoverflow)
PL (2) PL170726B1 (enrdf_load_stackoverflow)
RU (1) RU2077532C1 (enrdf_load_stackoverflow)
TW (1) TW200463B (enrdf_load_stackoverflow)
ZA (1) ZA921268B (enrdf_load_stackoverflow)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
TW232013B (enrdf_load_stackoverflow) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
DE4301900A1 (de) * 1993-01-25 1994-07-28 Bayer Ag 2-Oxochinolin-1-yl-methylphenylessigsäurederivate
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries, Ltd. Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
HUP0103714A3 (en) * 1998-05-11 2003-05-28 Takeda Pharmaceutical Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity, medicaments containing them and their use
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
JP4598278B2 (ja) * 1999-04-28 2010-12-15 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｐｐａｒ受容体リガンドとしてのジアリール酸誘導体
RU2177317C1 (ru) * 2000-10-24 2001-12-27 Московский научно-исследовательский институт медицинской экологии (МНИИМЭ) Производные хинолина для коррекции системы гемостаза, фармацевтическая композиция, средство для коррекции гемостаза
TWI309644B (enrdf_load_stackoverflow) * 2001-02-14 2009-05-11 Nissan Chemical Ind Ltd
US6867320B2 (en) 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
WO2005058834A2 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
CN101044135B (zh) * 2004-10-19 2011-11-23 霍夫曼-拉罗奇有限公司 喹啉衍生物
PT2125786E (pt) * 2006-12-21 2011-04-21 Pfizer Prod Inc Sal succinato de 2-((4-(1-metil-4-(piridin-4-il)-1hpirazol- 3-il)fenoxi)metil)quinolina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3908298A1 (de) * 1989-03-14 1990-09-20 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-n,n'-sulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate

Also Published As

Publication number Publication date
EP0499926B1 (de) 1996-09-11
CZ282723B6 (cs) 1997-09-17
FI920732A0 (fi) 1992-02-20
FI920732L (fi) 1992-08-23
RU2077532C1 (ru) 1997-04-20
IL101009A (en) 1996-08-04
JPH0592957A (ja) 1993-04-16
HU9200582D0 (en) 1992-05-28
EP0499926A1 (de) 1992-08-26
PL171026B1 (pl) 1997-02-28
DE59207074D1 (de) 1996-10-17
PL170726B1 (pl) 1997-01-31
IE920557A1 (en) 1992-08-26
DE4105551A1 (de) 1992-08-27
KR920016424A (ko) 1992-09-24
IL101009A0 (en) 1992-11-15
AU641585B2 (en) 1993-09-23
NZ241654A (en) 1994-11-25
TW200463B (enrdf_load_stackoverflow) 1993-02-21
PL293534A1 (en) 1992-10-05
HUT67037A (en) 1995-01-30
ZA921268B (en) 1992-11-25
ES2091958T3 (es) 1996-11-16
FI920732A7 (fi) 1992-08-23
AU1054292A (en) 1992-08-27
GR3021014T3 (en) 1996-12-31
MY108459A (en) 1996-09-30
ATE142623T1 (de) 1996-09-15
CS51492A3 (en) 1992-12-16
DK0499926T3 (enrdf_load_stackoverflow) 1997-02-10

Similar Documents

Publication Publication Date Title
IE75728B1 (en) 2-substituted quinolines processes for their preparation and their use in medicaments
AU614358B2 (en) Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acids and -esters
KR101461291B1 (ko) 약학적 활성 화합물의 제조 방법
CA2017135C (en) Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments
US5192771A (en) (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents
US5179106A (en) Substituted n-(quinolin-2-yl-methoxy) benzyl-sulphonylurea leukotriene synthesis inhibitors
US6605722B2 (en) Tyrosine derivatives with anti-leukotrienen activity
CN101220021A (zh) 4-取代苯氧基喹啉类化合物及其中间体、制备方法和应用
AU660742B2 (en) Thiazolyl-substituted quinolylmethoxphenylacetic acid derivatives
US5266578A (en) Heterocyclically substituted quinolylmethoxy-phenylacetamides
CA2076929A1 (en) Substituted mandelic acid derivatives, processes for their preparation and their use in medicaments
US5597833A (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
EP1408033A1 (en) Dibenzocycloheptene compound
US5304563A (en) 2-substituted quinolines, and their use in medicaments
US5310744A (en) Quinolylmethoxyphenyl-acetamides
NZ232861A (en) N-(quinolin-2-yl)methoxy phenyl-n'-sulphonylurea derivatives, preparation and pharmaceutical composition thereof
AU669913B2 (en) New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides
KR101323664B1 (ko) 몬테루카스트 제조방법과 이를 위한 중간체

Legal Events

Date Code Title Description
MM4A Patent lapsed